List of works by Kushtrim Kryeziu

Chronic arsenic trioxide exposure leads to enhanced aggressiveness via Met oncogene addiction in cancer cells

scientific article published on 28 March 2016

Destruxins: fungal-derived cyclohexadepsipeptides with multifaceted anticancer and antiangiogenic activities

scientific article published on 6 June 2013

Long-term exposure of immortalized keratinocytes to arsenic induces EMT, impairs differentiation in organotypic skin models and mimics aspects of human skin derangements.

scientific article published on 3 August 2017

Macromolecular Pt(IV) Prodrugs from Poly(organo)phosphazenes.

scientific article

Nanoformulations of anticancer thiosemicarbazones to reduce methemoglobin formation and improve anticancer activity

scholarly article in RSC Advances, vol. 6 no. 61, 2016

Poly(lactic acid) nanoparticles of the lead anticancer ruthenium compound KP1019 and its surfactant-mediated activation

scientific article published on 29 October 2013

Sensitivity towards the GRP78 inhibitor KP1339/IT-139 is characterized by apoptosis induction via caspase 8 upon disruption of ER homeostasis.

scientific article published on 14 July 2017

Structure-Related Mode-of-Action Differences of Anticancer Organoruthenium Complexes with β-Diketonates

scientific article

Synergistic anticancer activity of arsenic trioxide with erlotinib is based on inhibition of EGFR-mediated DNA double-strand break repair

scientific article published on 2 April 2013

The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo

scientific article published on 18 June 2013

The study of reduced versus oxidized glutathione in cancer cell models employing isotopically labelled standards

Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro

scientific article published on 10 August 2016

Tumor-targeting of EGFR inhibitors by hypoxia-mediated activation

scientific article published on 30 July 2014

Tumorspezifische, Hypoxie-basierte Aktivierung von EGFR-Inhibitoren

Water-Soluble, Biocompatible Polyphosphazenes with Controllable and pH-Promoted Degradation Behavior

scientific article

[11C]Erlotinib PET cannot detect acquired erlotinib resistance in NSCLC tumor xenografts in mice.

scientific article

Paulina is supported by:

About Paulina

Help